Does Pepcid (Famotidine) Cause Low Magnesium?
No, famotidine does not cause hypomagnesemia through the same mechanisms as proton pump inhibitors, and the FDA label does not list magnesium depletion as a recognized adverse effect. 1
Evidence from FDA Drug Labeling
The official Pepcid prescribing information makes no mention of hypomagnesemia or magnesium monitoring requirements in its precautions, adverse effects, or clinical pharmacology sections. 1 This stands in stark contrast to proton pump inhibitors (PPIs), which are well-established causes of magnesium depletion. 2
Distinction from Proton Pump Inhibitors
While PPIs (the more potent acid suppressors) have been inconsistently associated with reductions in magnesium, vitamin B12, iron, and calcium status, famotidine is an H2-receptor antagonist with a different mechanism of action and lower potency for acid suppression. 2 The guideline literature specifically discusses PPI-related micronutrient deficiencies but does not implicate H2-antagonists like famotidine in causing hypomagnesemia. 2
Isolated Case Report
One case report from 2020 described a 55-year-old woman who developed hypomagnesemia and hypocalcemia after 2 years of famotidine 20 mg twice daily. 3 However, this represents an extremely rare occurrence:
- Single case in the literature with no mechanistic explanation provided 3
- Extensive workup was unrevealing for other causes, but causality remains uncertain 3
- Symptoms resolved after discontinuation, though this temporal association alone does not prove causation 3
Clinical Implications
- Routine magnesium monitoring is not indicated for patients on famotidine therapy 1
- If hypomagnesemia develops in a patient taking famotidine, investigate other more common causes first (diuretics, PPIs, antibiotics like aminoglycosides, antineoplastics like cisplatin, calcineurin inhibitors) 4
- Consider famotidine as a potential contributor only after excluding more established causes of magnesium depletion 4
- No dose adjustments or special precautions related to magnesium are recommended in the FDA labeling 1
Common Pitfall
Do not confuse famotidine (an H2-antagonist) with PPIs when counseling patients about micronutrient risks. The evidence for magnesium depletion with acid suppression primarily applies to PPIs, not H2-blockers like famotidine. 2